{"id":"https://genegraph.clinicalgenome.org/r/5be1e7b9-3157-4208-919f-6e9552b71ecev1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *IBA57* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of July 11, 2023. *IBA57* encodes an iron-sulfur cluster assembly protein that acts late in the biosynthetic pathway of mitochondrial 4Fe-4S proteins. \n\n*IBA57* was first reported in relation to autosomal recessive primary mitochondrial disease in 2013 (PMID: 23462291), in a neonate with intrauterine growth restriction, brain malformations detected in utero, hypotonia, microcephaly, and hyperglycinemia who died perinatally.  While various names have been given to the constellation of features seen in those with *IBA57*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *IBA57* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework.\n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six unique variants (three missense, two nonsense, and one predicted missense variant resulting in splicing abnormalities), in five probands across four publications (PMIDs: 23462291, 25971455, 25609768, 28913435). Compelling familial segregation data was also included in scoring (PMID: 25609768). There are at least 50 cases reported in the literature through 2022 (PMID: 36360281). Two general clinical phenotypes have been reported. One is an infantile onset, sometimes fatal, microcephaly and cavitating leukodystrophy with or without other brain malformations with metabolic acidosis and hyperglycinemia. The other is childhood/adolescent onset spastic paraplegia with or without optic atrophy. Notably, this second phenotype is reported in relation to a variant impacting splicing. Affected individuals show reduction in activities and amounts of lipoate containing enzymes (PMIDs: 23462291, 25971455, 25609768, 28913435). \n \nThis gene-disease association is also supported by functional implication given protein interaction with other proteins of the Fe-S cluster biosynthesis and assembly machinery and the lipoylation pathway, as well as functional alteration in patient cells (PMIDs: 33007329, 27785568). \n\nIn summary, there is definitive evidence to support the relationship between *IBA57* and primary mitochondrial disease. This has been repeatedly demonstrated and upheld over time, and no convincing evidence has emerged that contradicts this gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on July 11, 2023 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5be1e7b9-3157-4208-919f-6e9552b71ece","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-01-16T15:50:03.362Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2023-07-11T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea2a66f9-ce6a-480e-9810-b92c7bc87b2d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66db66ef-f46d-4f7f-abe8-5eabb3e807a5","type":"EvidenceLine","dc:description":"myoblast and fibroblast studies confirm reduced (but not absent IBA57)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66db66ef-f46d-4f7f-abe8-5eabb3e807a5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"myoblast and fibroblast studies confirm reduced (but not absent IBA57)","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/66db66ef-f46d-4f7f-abe8-5eabb3e807a5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","allele":{"id":"https://genegraph.clinicalgenome.org/r/26c3f783-a8e4-42e9-9b11-dfe2c08631fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.150C>A (p.Cys50Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345105145"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/333f3079-7bf0-4567-9c5a-e31609f7b29c","type":"EvidenceLine","dc:description":"0.1 + 0.4 (substantially decreased IBA57, small amount of full length IBA57)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/333f3079-7bf0-4567-9c5a-e31609f7b29c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 + 0.4 (substantially decreased IBA57, small amount of full length IBA57)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/333f3079-7bf0-4567-9c5a-e31609f7b29c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","allele":{"id":"https://genegraph.clinicalgenome.org/r/084c4260-a885-4b45-8ee4-d90219062e95","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.323A>C (p.Tyr108Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345106787"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea2a66f9-ce6a-480e-9810-b92c7bc87b2d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","rdfs:label":"Family B, II-1 (aka patient 3)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/26c3f783-a8e4-42e9-9b11-dfe2c08631fe"},{"id":"https://genegraph.clinicalgenome.org/r/084c4260-a885-4b45-8ee4-d90219062e95"}],"detectionMethod":"p.Y108S frequency in gnomAD v3.1.2 (af 0.000006578, only 1 allele\np. C50X is not reported in gnomAD v3.1.2","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001257","obo:HP_0001263","obo:HP_0033369"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/333f3079-7bf0-4567-9c5a-e31609f7b29c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/66db66ef-f46d-4f7f-abe8-5eabb3e807a5_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/e1d81ad0-1b0f-4e22-801f-ec2edfd6f764_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6091341e-c75a-4336-af67-470caa4a0643","type":"EvidenceLine","dc:description":"0.1 (rare missense variant) + 0.4 (I (-4 Z score), II (-6 Z score), II+III (-7 Z score) deficiency in muscle) + 0.4 (Reduced complex I and II by BN PAGE and WB) + 0.4 (HeLA cells study showing R146W has complex II and IV activities similar to siRNA knockdown (which is rescued with WT IBA57)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6091341e-c75a-4336-af67-470caa4a0643_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (rare missense variant) + 0.4 (I (-4 Z score), II (-6 Z score), II+III (-7 Z score) deficiency in muscle) + 0.4 (Reduced complex I and II by BN PAGE and WB) + 0.4 (HeLA cells study showing R146W has complex II and IV activities similar to siRNA knockdown (which is rescued with WT IBA57)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6091341e-c75a-4336-af67-470caa4a0643_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25971455","allele":{"id":"https://genegraph.clinicalgenome.org/r/459adfc3-e693-495c-babf-0ee29bd2e911","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.436C>T (p.Arg146Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA38741683"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/e1d81ad0-1b0f-4e22-801f-ec2edfd6f764","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25971455","rdfs:label":"Debray et al Patient ","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/459adfc3-e693-495c-babf-0ee29bd2e911"},"detectionMethod":"Both parents were heterozygous for the mutation\ngnomAD v3.1.2 AF 0.000006571 (1 allele)","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001324","obo:HP_0002376","obo:HP_0002154","obo:HP_0001252","obo:HP_0007204"],"previousTesting":true,"previousTestingDescription":"SNP array identified loss of heterozygosity in large chromosomal regions, covering the NFU1 and BOLA3, and the IBA57 and ABCB10 candidate genes,","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6091341e-c75a-4336-af67-470caa4a0643_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/3a8dc40d-1858-4401-90a3-4a3c3d0a1f6a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89ad0579-9a44-45a0-8db6-80392fd69d67","type":"EvidenceLine","dc:description":"0.1 (other - splicing that does not seem to undergo NMD) + 0.4 (retention of intron 2 + frameshift and premature truncation at 280/356 amino acids)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89ad0579-9a44-45a0-8db6-80392fd69d67_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (other - splicing that does not seem to undergo NMD) + 0.4 (retention of intron 2 + frameshift and premature truncation at 280/356 amino acids, (10-20% of wildtype length retained))","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/89ad0579-9a44-45a0-8db6-80392fd69d67_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25609768","allele":{"id":"https://genegraph.clinicalgenome.org/r/0095c764-f55c-4f2b-b186-be8726827b28","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.678A>G (p.Gln226=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575730"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/3a8dc40d-1858-4401-90a3-4a3c3d0a1f6a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25609768","rdfs:label":"Patient IV-7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":39,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0095c764-f55c-4f2b-b186-be8726827b28"},"detectionMethod":"Not reported in gnomAD v3.1.2\n\nRestriction analysis-based screening of the entire family using PstI showed perfect segregation, with homozygosity found only in the patients (not shown - 11 affected individuals are genotype +) \n\nTo evaluate the predicted outcome of this mutation, we studied cDNA obtained from both fresh\nlymphocytes and transformed lymphoblastoid cells of patient III-5. A prominent 692-bp PCR product was identified with a fainter band (approximately 10%â€“20%) of 599 bp corresponding to the predicted normal splicing product (figure 2C). Sequencing analysis of the larger fragment revealed that this transcript retained intron 2, which is altogether 93 bp. This aberrant transcript with the inserted intron leads to a frameshift and is predicted to generate a truncated protein with only 280 amino acid residues (normal protein is 356 amino acids)\n\n","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"10 years at gait abnormality onset","phenotypes":["obo:HP_0002313","obo:HP_0009830","obo:HP_0000648"],"previousTesting":false,"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/89ad0579-9a44-45a0-8db6-80392fd69d67_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d74d2958-aec3-4f94-8dbd-45311cdeeb8e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d57b1124-4f31-45bb-9e5a-365330efbeeb","type":"EvidenceLine","dc:description":"0.1 + 0.4 (absent IBA57 on WB in fibros and muscle) + 0.4 (complex I (-5Z score) and II (-9 Z score) deficiency in muscle) + 0.4 (BN PAGE showed reduced complex I and II with normal III and V and borderline low IV) + 0.4 (HeLA cells studies with RNAi Knockdown in knockin of variant mtACO, CII, CIV, were partially restored on co-transfection with wildtype IBA57. In contrast, mutated IBA57_Q314P was hardly effective in reversing the loss in enzyme activities)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d57b1124-4f31-45bb-9e5a-365330efbeeb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 + 0.4 (absent IBA57 on WB in fibros and muscle) + 0.4 (complex I (-5Z score) and II (-9 Z score) deficiency in muscle) + 0.4 (BN PAGE showed reduced complex I and II with normal III and V and borderline low IV) + 0.4 (HeLA cells studies with RNAi Knockdown in knockin of variant mtACO, CII, CIV, were partially restored on co-transfection with wildtype IBA57. In contrast, mutated IBA57_Q314P was hardly effective in reversing the loss in enzyme activities)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d57b1124-4f31-45bb-9e5a-365330efbeeb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23462291","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe7ca6d4-a5ec-4de3-8682-b0e2bf5b35c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.941A>C (p.Gln314Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144513"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/d74d2958-aec3-4f94-8dbd-45311cdeeb8e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23462291","rdfs:label":"Bolar P1","ageType":"AgeAtOnset","ageUnit":"Hours","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fe7ca6d4-a5ec-4de3-8682-b0e2bf5b35c9"},"detectionMethod":"Homozygous regions screened for iron sulfur cluster genes based on spectrophotometry and BN PAGE results + (reduced lipoic acid content of aKDH and PDH in muscle and fibros) \np.Gln314Pro absent in gnomAD v.3.1.2","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"MRI showed white matter abnormalities, a hypoplasia of the\ncorpus callosum, bilateral frontoparietal polymicrogyria,\nhypoplasia of the medulla oblongata and cytotoxic edema of\nthe cortex affecting the left frontal and both occipital lobes\n","phenotypes":["obo:HP_0001324","obo:HP_0002154","obo:HP_0001252","obo:HP_0002079","obo:HP_0000252","obo:HP_0001942","obo:HP_0001511","obo:HP_0005684","obo:HP_0001561","obo:HP_0002126","obo:HP_0002500"],"previousTesting":true,"previousTestingDescription":"GLDC and AMT sequenced for glycine encephalopathy","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d57b1124-4f31-45bb-9e5a-365330efbeeb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/189745e3-cbdc-49c6-8903-09eba2a6c99f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25609768","rdfs:label":"Lossos et al Family ","estimatedLodScore":6.02,"family":{"id":"https://genegraph.clinicalgenome.org/r/189745e3-cbdc-49c6-8903-09eba2a6c99f","type":"Family","rdfs:label":"Lossos et al Family ","member":{"id":"https://genegraph.clinicalgenome.org/r/3a8dc40d-1858-4401-90a3-4a3c3d0a1f6a"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":11,"phenotypes":["obo:HP_0001138","obo:HP_0001258","obo:HP_0009830"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3a8dc40d-1858-4401-90a3-4a3c3d0a1f6a"},"publishedLodScore":3.2,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2cc6ab88-f835-40fd-8420-74c39bf665cc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/838e39d2-d743-43bd-97f8-bccc63726305","type":"EvidenceLine","dc:description":"1.5 - 0.5 (could escape NMD) ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/838e39d2-d743-43bd-97f8-bccc63726305_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Truncates roughly 12% of protein, could escape NMD (elected to score as null given >10% truncation  (Richards 2015 score as PVS1_Strong) with penalty 0.5)","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/838e39d2-d743-43bd-97f8-bccc63726305_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4b38148-60f8-44d8-b947-32f59fc70021","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001010867.4(IBA57):c.940C>T (p.Gln314Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345116786"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ae826597-2a37-459d-803b-bd97daf6b6d1","type":"EvidenceLine","dc:description":"0.1 + 0.4 (substantially decreased IBA57, small amount of full length IBA57)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae826597-2a37-459d-803b-bd97daf6b6d1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 + 0.4 (substantially decreased IBA57, small amount of full length IBA57)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ae826597-2a37-459d-803b-bd97daf6b6d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","allele":{"id":"https://genegraph.clinicalgenome.org/r/084c4260-a885-4b45-8ee4-d90219062e95"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2cc6ab88-f835-40fd-8420-74c39bf665cc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28913435","rdfs:label":"Family A, Patient II-2 (aka Patient 1)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b4b38148-60f8-44d8-b947-32f59fc70021"},{"id":"https://genegraph.clinicalgenome.org/r/084c4260-a885-4b45-8ee4-d90219062e95"}],"detectionMethod":"p.Y108S frequency in gnomAD v3.1.2 (af 0.000006578, only 1 allele\np. Gln314X is not reported in gnomAD v3.1.2","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Mild cognitive impairment ","phenotypes":["obo:HP_0001263","obo:HP_0033369","obo:HP_0001250","obo:HP_0001371"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ae826597-2a37-459d-803b-bd97daf6b6d1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/838e39d2-d743-43bd-97f8-bccc63726305_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc8df806-dd86-43ed-9688-b689483d1044","type":"EvidenceLine","dc:description":"0.5 for WB showing decreased IBA57 and decrease RC proteins + 0.5 decreased activity of lipoylated DHs ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6605109b-3667-4630-b24c-744574e8c3c0","type":"FunctionalAlteration","dc:description":"-Reduced IBA57 by Western Blot, Reduced NDUFS1, SDHA, SDHB by Western Blot\n-Significantly reduced PDHc, aKGDHc, and BCKDHc (branched chain keto acid dehydrogenase) activities in this patient's fibroblasts (lipoylated DHs)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27785568","rdfs:label":"Fibroblasts studies on Torraco Patient 1 "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bdce99ba-3bad-4f5b-b270-e6f05a1cee8c","type":"EvidenceLine","dc:description":"0.5 - Decreased IBA57 by WB, Decreased SDHB by WB + 0.5 Decreased activity of PDHc, aKGDHc, BCKHDc","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40ef4de3-1898-46b0-b34b-e8315e09ac44","type":"FunctionalAlteration","dc:description":"Decreased IBA57 by WB, Decreased SDHB by WB\nDecreased activity of PDHc, aKGDHc, BCKHDc","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27785568","rdfs:label":"Toracco et al patient 3 fibroblast studies "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a005d270-eb33-4843-9ea8-2ee58f443437_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c79fdc1-7f1e-451f-a4f3-6f608573db5d","type":"EvidenceLine","dc:description":">10 genes involved in late ISC machinery (4fe-4S) including LIAS, complex I, mAco, and direct interactions with ISCA1 and ISCA2","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db14c8b0-4b03-4a2b-9e33-805fee238c1e","type":"Finding","dc:description":"all genes listed have been linked to mitochondrial diseases ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33007329","rdfs:label":"Overview of Iron Sulfur protein biogenesis in biology ","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":7553,"specifiedBy":"GeneValidityCriteria9","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/SOPDKM7sLP0","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:27302","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a005d270-eb33-4843-9ea8-2ee58f443437-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}